Top 20 of Arthritis, Rheumatoid

Article title # Publications/# Citations

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

1988: FCArnett; DABloch; NSCooper; SMEdworthy; JFFries; LAHealey; SRKaplan; MHLiang; HSLuthra; DJMcShane;

2436

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.

2007: Wellcome Trust Case Control Consortium;

2435

Angiogenesis in cancer, vascular, rheumatoid and other disease.

1995: JFolkman;

895

Free radicals and antioxidants in normal physiological functions and human disease.

2006: MTCronin; DLeibfritz; MMazur; JMoncoľ; JTelser; MValko;

608

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

1995: HHKuper; MLPrevoo; MAvan 't Hof; LBvan de Putte; MAvan Leeuwen; PLvan Riel;

502

Measurement of patient outcome in arthritis.

1980: JFFries; HRHolman; RGKraines; PSpitz;

390

1958 Revision of diagnostic criteria for rheumatoid arthritis.

1958: GABennett; SCobb; RJacox; RAJessar; MWRopes;

388

Evolving concepts of rheumatoid arthritis.

2003: GSFirestein;

370

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

2000: Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group; FCBreedveld; PEmery; MFeldmann; DEFurst; GRHarriman; JRKalden; PELipsky; ... RNMaini; JSSmolen; EWSt Clair; DMvan der Heijde; MWeisman;

357

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.

2001: MMBraun; SGershon; JKasznica; JKeane; EMirabile-Levens; WDSchwieterman; JNSiegel; RPWise;

347

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.

2000: VIGOR Study Group; CBombardier; RBurgos-Vargas; BDavis; RDay; MBFerraz; CJHawkey; MCHochberg; ... TKKvien; LLaine; AReicin; TJSchnitzer; DShapiro;

341

The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis.

1987: PKGregersen; JSilver; RJWinchester;

340

Oxygen toxicity, oxygen radicals, transition metals and disease.

1984: JMGutteridge; BHalliwell;

336

Role of cytokines in rheumatoid arthritis.

1996: FMBrennan; MFeldmann; RNMaini;

300

Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence.

2000: TWCroghan; MRDiMatteo; HSLepper;

294

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.

2004: DRClose; JCEdwards; PEmery; AFilipowicz-Sosnowska; TShaw; RMStevens; LSzczepanski; JSzechinski;

283

A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis.

2004: HCAlexander; CIAmos; KGArdlie; FBatliwalla; ABBegovich; VECarlton; JJCatanese; MChang; ... SYChang; APChokkalingam; MTConn; LACriswell; VEGarcía; PKGregersen; LAHonigberg; QHuang; DAJeffery; DLKastner; ATLee; DULeong; LBMcAllister; ERemmers; RKSaiki; SJSchrodi; MFSeldin; AMSmith; JJSninsky; JMSpoerke;

275

The Sickness Impact Profile: development and final revision of a health status measure.

1981: MBergner; RABobbitt; WBCarter; BSGilson;

271

DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association.

1959:

270

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.

1999: FBreedveld; PEmery; MFeldmann; DFürst; GHarriman; JKalden; PLipsky; RMaini; ... JSmolen; EWSt Clair; MWeisman;

252